Voiglim TRIO 1

Voiglim-TRIO-1 by Voithea Healthcare is an advanced anti-diabetic combination that includes Glimepiride 1mg, Metformin 500mg, and Pioglitazone 15mg, designed to provide broad-spectrum glycemic control in type 2 diabetes. Glimepiride boosts insulin secretion, Metformin reduces hepatic glucose production and enhances insulin sensitivity, while Pioglitazone improves peripheral glucose uptake by modulating insulin action at the cellular level.

This triple-drug therapy is ideal for patients who require intensified treatment to manage blood sugar levels effectively. Voiglim-TRIO-1 offers a synergistic approach that targets multiple pathways in diabetes management, ensuring sustained control and improved metabolic outcomes. It reflects Voithea Healthcare’s dedication to delivering high-quality, patient-centric diabetic care.